Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America
- PMID: 34563640
- DOI: 10.1016/j.canlet.2021.09.034
Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America
Abstract
Colorectal cancer (CRC) is one of the most common malignancies worldwide. China, Europe and northern America account for more than half of the new CRC cases and associated deaths globally. This review summarizes the current status and temporal trends of CRC in China, Europe, and northern America. The potential primary preventive strategies and latest advances in CRC screening techniques and programs are discussed. Recently, the incidence and mortality of CRC in some European and northern American countries have decreased; conversely, CRC incidence and mortality continue to increase in China. The overall 5-year relative survival rate for CRC is similar between these regions, but there is considerable heterogeneity among European countries. Implementing population-based CRC screening programs can effectively address the growing disease burden. The effectiveness of nationwide CRC screening programs in these regions has been limited by relatively low coverage and participation rate. The deployment of state-of-the-art techniques and precise risk-adapted screening strategies incorporating effective risk prediction models and screening techniques may boost screening effectiveness. Our review provides novel foundations for the development and optimization of CRC preventive strategies.
Keywords: Burden; Colorectal cancer; Risk factor; Screening; Survival.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review.Eur J Cancer. 2020 Mar;127:224-235. doi: 10.1016/j.ejca.2019.12.014. Epub 2020 Jan 10. Eur J Cancer. 2020. PMID: 31932176
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038. CA Cancer J Clin. 2009. PMID: 19897840 Review.
-
Risk-Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome.Aliment Pharmacol Ther. 2025 Feb;61(4):675-681. doi: 10.1111/apt.18435. Epub 2024 Dec 16. Aliment Pharmacol Ther. 2025. PMID: 39686687 Free PMC article.
-
Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location.Clin Gastroenterol Hepatol. 2021 May;19(5):955-966.e61. doi: 10.1016/j.cgh.2020.02.026. Epub 2020 Feb 21. Clin Gastroenterol Hepatol. 2021. PMID: 32088300
-
Participation and yield of a population-based colorectal cancer screening programme in China.Gut. 2019 Aug;68(8):1450-1457. doi: 10.1136/gutjnl-2018-317124. Epub 2018 Oct 30. Gut. 2019. PMID: 30377193
Cited by
-
Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy.Ther Adv Med Oncol. 2024 Feb 11;16:17588359241229434. doi: 10.1177/17588359241229434. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38347922 Free PMC article.
-
MicroRNA-455-3p accelerate malignant progression of tumor by targeting H2AFZ in colorectal cancer.Cell Cycle. 2023 Apr;22(7):777-795. doi: 10.1080/15384101.2022.2154549. Epub 2022 Dec 8. Cell Cycle. 2023. PMID: 36482739 Free PMC article.
-
Risk factors for early-onset colorectal cancer: A large-scale Chinese cohort study.J Natl Cancer Cent. 2023 Jan 15;3(1):28-34. doi: 10.1016/j.jncc.2023.01.001. eCollection 2023 Mar. J Natl Cancer Cent. 2023. PMID: 39036307 Free PMC article.
-
Lentinan-functionalized selenium nanoparticles induce apoptosis and cell cycle arrest in human colon carcinoma HCT-116 cells.Front Nutr. 2022 Aug 23;9:987807. doi: 10.3389/fnut.2022.987807. eCollection 2022. Front Nutr. 2022. PMID: 36082027 Free PMC article.
-
Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery.Front Oncol. 2023 Feb 9;13:1128383. doi: 10.3389/fonc.2023.1128383. eCollection 2023. Front Oncol. 2023. PMID: 36845740 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical